SCHEMBL4860109

SCHEMBL4860109

CCCCCCCCCCCCCCCCc1nccc(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.43
GPR84 Q9NQS5 1/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
DGAT1 O75907 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ESR1 P03372 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
TACR2 P21452 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
SHBG P04278 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84523 0.98 KCNH2 (0.40) KCNH2GPR84CNR1CNR2DGAT1
SCHEMBL15057850 0.93 MEN1 (0.38) KCNH2GPR84DGAT1TDP1L3MBTL1
SCHEMBL27457526 0.85 NOS2 (0.36) TDP1L3MBTL1KDM4EALDH1A1LMNA
SCHEMBL27769288 0.80 KCNH2 (0.58) KCNH2GPR84TDP1L3MBTL1ESR1
SCHEMBL27634918 0.80 KCNH2 (0.44) KCNH2GPR84TDP1L3MBTL1ESR1
SCHEMBL27977748 0.80 KCNH2 (0.58) KCNH2GPR84TDP1L3MBTL1ESR1
SCHEMBL11310160 0.80 KCNH2 (0.44) KCNH2GPR84TDP1L3MBTL1ESR1
SCHEMBL11334282 0.79 KCNH2 (0.43) KCNH2GPR84TDP1L3MBTL1ESR1
SCHEMBL29172695 0.79 KCNH2 (0.43) KCNH2GPR84ADORA3KDM4EALDH1A1
Ammonia Solution, Strong SCHEMBL28527210 0.79 KCNH2 (0.56) KCNH2GPR84DGAT1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888138-B1 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM ABIOMED INC (US) 2013-09-04 EP claimed
JP-2008544769-A 2008-12-11 JP claimed
EP-1888138-A2 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM Abiomed, Inc. (US) 2008-02-20 EP claimed
WO-2006121908-A2 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM ABIOMED, INC. (US) 2006-11-16 WO claimed
US-20060257355-A1 Impregnated polymer compositions and devices using them ABIOMED, INC. (US) 2006-11-16 US claimed
EP-1888138-B1 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM ABIOMED INC (US) 2013-09-04 EP disclosed
EP-1888138-A2 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM Abiomed, Inc. (US) 2008-02-20 EP disclosed
WO-2006121908-A2 IMPREGNATED POLYMER COMPOSITIONS AND DEVICES USING THEM ABIOMED, INC. (US) 2006-11-16 WO disclosed
US-20060257355-A1 Impregnated polymer compositions and devices using them ABIOMED, INC. (US) 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060257355-A1 Impregnated polymer compositions and devices using them CD47, CD99, FGB KCNH2 4243/4885GPR84 2573/4885CNR1 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.